A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
A medical condition which makes a particular drug treatment or procedure advisable in line with the Product License. Drug approvals for specific indications are controlled in most countries and jurisdictions by a licensing body, including the Food and Drug Administration (FDA) in the US and the European Medical Association (EMA) in the EU.
See also:
Food And Drug Administration (FDA)
License (product)
New Drug Application (NDA), Drug tariff, Field experiments, Trial endpoint, Methodology, Ansoff Matrix, Placebo effect, Meta analysis, Generic name, Baseline, Fair balance, Clinical trial, Outlier, Blind (clinical trial terms), Cost-minimisation analysis (CMA),
No results were found
Genesis Research Group provides life science companies with a better way to develop impactful evidence and optimize market access by...